{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:53:29Z","timestamp":1791212009648,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To identify the clinical and physiologic factors associated with mortality in pediatric patients with persistent inflammation, immunosuppression, and catabolism syndrome (PIICS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Secondary analysis of a single-center cohort, 2019\u20132024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>PICU at a tertiary children\u2019s hospital in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>We reviewed data on all patients younger than 21 years who had been admitted to the PICU for greater than or equal to 15 consecutive days between 2019 and 2024. Pediatric PIICS was defined as: C-reactive protein greater than 2\u2009mg\/dL, albumin less than 3\u2009g\/dL, and lymphocyte count less than 800\/\u00b5L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>Among 536 patients, we identified 64 who met criteria for pediatric PIICS. Cox proportional hazards models were used to examine factors associated with greater hazard of mortality, and proportional hazards assumptions were assessed using hazard smoothing. In the primary time-to-event analysis, severity of diarrhea, maximum heart rate ratio (mHR-r), and cumulative hypotension exposure were associated with greater hazard of mortality. The Youden-derived cutoffs were 6.5 for diarrheal severity, 1.67 for mHR-r, and 63 hours for cumulative hypotension exposure. Analysis of Kaplan-Meier curves showed that lower survival was associated with data above these thresholds. However, in the sensitivity analyses evaluating confounding by case-mix and baseline severity, we failed to identify that diarrhea was associated with greater odds of mortality. Cumulative hypotension exposure and mHR-r remained consistent physiologic markers associated with greater hazard of mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this secondary analysis of pediatric patients with PIICS, the mHR-r and cumulative hypotension exposure were associated with greater hazard of mortality. Severe diarrhea showed an association with mortality in the primary time-to-event analysis, but we failed to identify such an association after adjustment for case-mix and baseline severity. These findings suggest that diarrhea may be a clinically relevant marker of gastrointestinal dysfunction, but its prognostic role remains uncertain. Larger multicenter studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000004063","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:01:08Z","timestamp":1791208868000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Children: Associations With Outcomes in a Secondary Analysis of a 2019\u20132024 Cohort"],"prefix":"10.1097","author":[{"given":"Soichiro","family":"Tanimura","sequence":"first","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisaku","family":"Nashiki","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Tsubokura","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Hinotsu","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management, Sapporo Medical University, Hokkaido, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"R1-20261005","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/PCC.0000000000003625","article-title":"Application of persistent inflammation, immunosuppression, and catabolism syndrome to critically ill children: Single-center retrospective cohort, 2019-2023.","volume":"26","author":"Tanimura","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20261005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/sur.2015.184","article-title":"Persistent inflammation, immunosuppression, and catabolism: Evolution of multiple organ dysfunction.","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Surg Infect"},{"key":"R3-20261005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/jcm9010191","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome (PICS) after polytrauma: A rare syndrome with major consequences.","volume":"9","author":"Hesselink","year":"2020","journal-title":"J Clin Med"},{"key":"R4-20261005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bja.2024.03.038","article-title":"Risk factors, biomarkers, and mechanisms for persistent inflammation, immunosuppression, and catabolism syndrome (PICS): A systematic review and meta-analysis.","volume":"133","author":"Chadda","year":"2024","journal-title":"Br J Anaesth"},{"key":"R5-20261005","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1097\/PCC.0000000000003449","article-title":"Pediatric sepsis phenotypes and outcome: 5-Year retrospective cohort in a single center in India (2017-2022).","volume":"25","author":"Sankar","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R6-20261005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PCC.0000000000003499","article-title":"Biomarker assessment of a high-risk, data-driven pediatric sepsis phenotype characterized by persistent hypoxemia, encephalopathy, and shock.","volume":"25","author":"Atreya","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20261005","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1097\/PCC.0000000000003708","article-title":"Pediatric sepsis phenotype in a single-center cohort covering 2010-2020: evolution in day 1 \u2013 Day 3 trajectory and potential prognostic value.","volume":"26","author":"Aldewereld","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20261005","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1097\/PCC.0000000000003789","article-title":"Derivation and validation of pediatric sepsis-associated acute kidney injury subphenotypes with prognostic relevance.","volume":"26","author":"Stanski","year":"2025","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20261005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PCC.0000000000003902","article-title":"Plasma linoleic acid is associated with pediatric sepsis phenotype and acute kidney injury.","volume":"27","author":"Saraiva","year":"2026","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20261005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jhn.12798","article-title":"Persistent inflammation, immunosuppression and catabolism syndrome (PICS) in critically ill children is associated with clinical outcomes: A prospective longitudinal study.","volume":"34","author":"Hauschild","year":"2021","journal-title":"J Hum Nutr Diet"},{"key":"R11-20261005","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3390\/jcm11195790","article-title":"Clinical criteria for persistent inflammation, immunosuppression, and catabolism syndrome: An exploratory analysis of optimal cut-off values for biomarkers.","volume":"11","author":"Nakamura","year":"2022","journal-title":"J Clin Med"},{"key":"R12-20261005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chest.2023.05.002","article-title":"Pediatric persistent inflammation, immunosuppression, and catabolism syndrome prevalence in sepsis-related mortalities: A 23-year institutional history.","volume":"164","author":"Patterson","year":"2023","journal-title":"Chest"},{"key":"R13-20261005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R14-20261005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jss.2022.04.052","article-title":"Early biomarker signatures in surgical sepsis.","volume":"277","author":"Madushani","year":"2022","journal-title":"J Surg Res"},{"key":"R15-20261005","first-page":"S876","article-title":"Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.","volume":"122","author":"Kleinman","year":"2010","journal-title":"Circulation"},{"key":"R16-20261005","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1818::AID-CNCR25>3.0.CO;2-0","article-title":"Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.","volume":"86","author":"Hinotsu","year":"1999","journal-title":"Cancer"},{"key":"R17-20261005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2307\/2531633","article-title":"Some diagnostic methods for Cox regression models through hazard smoothing.","volume":"46","author":"Gray","year":"1990","journal-title":"Biometrics"},{"key":"R18-20261005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated Pediatric Risk of Mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"R19-20261005","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1097\/PCC.0000000000003388","article-title":"Organ dysfunction in children with blood culture-proven sepsis: Comparative performance of four scores in a national cohort study.","volume":"25","author":"Schlapbach","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R20-20261005","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1097\/PCC.0000000000002985","article-title":"The zonulin pathway as a potential mediator of gastrointestinal dysfunction in critical illness.","volume":"23","author":"Martinez","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20261005","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1097\/CCM.0000000000003841","article-title":"Multi-compartmental profiling of bacterial and host metabolites identifies intestinal dysbiosis and its functional consequences in the critically ill child.","volume":"47","author":"Wijeyesekera","year":"2019","journal-title":"Crit Care Med"},{"key":"R22-20261005","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-022-13640-0","article-title":"Profiling gut microbiota and bile acid metabolism in critically ill children.","volume":"12","author":"Kean","year":"2022","journal-title":"Sci Rep"},{"key":"R23-20261005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/PCC.0000000000002929","article-title":"Temporal and spatial changes in the microbiome following pediatric severe traumatic brain injury.","volume":"23","author":"Rogers","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R24-20261005","doi-asserted-by":"crossref","first-page":"001888","DOI":"10.1099\/jmm.0.001888","article-title":"Lower gastrointestinal tract dysbiosis in persistent critical illness: A systematic review.","volume":"73","author":"Tang","year":"2024","journal-title":"J Med Microbiol"},{"key":"R25-20261005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-025-05309-7","article-title":"A review of gut failure as a cause and consequence of critical illness.","volume":"29","author":"Soranno","year":"2025","journal-title":"Crit Care"},{"key":"R26-20261005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/PCC.0000000000003458","article-title":"Automated calculator for the pediatric sequential organ failure assessment score: Development and external validation in a single-center 7-year cohort, 2015-2021.","volume":"25","author":"Akhondi-Asl","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R27-20261005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PCC.0000000000003457","article-title":"Dynamic prediction of mortality using longitudinally measured pediatric sequential organ failure assessment scores: A joint modeling approach.","volume":"25","author":"Akhondi-Asl","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R28-20261005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41390-024-03778-0","article-title":"Assessing bedside measures of autonomic nervous system dysregulation in the PICU.","volume":"98","author":"Badke","year":"2025","journal-title":"Pediatr Res"},{"key":"R29-20261005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PCC.0000000000003904","article-title":"Heart rate variability discriminates outcome after pediatric cardiac arrest.","volume":"27","author":"Mackie","year":"2026","journal-title":"Pediatr Crit Care Med"},{"key":"R30-20261005","doi-asserted-by":"crossref","first-page":"104907","DOI":"10.1016\/j.neubiorev.2022.104907","article-title":"Heart rate variability in the prediction of mortality: A systematic review and meta-analysis of healthy and patient populations.","volume":"143","author":"Jarczok","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"R31-20261005","doi-asserted-by":"crossref","first-page":"103116","DOI":"10.1016\/j.autneu.2023.103116","article-title":"Heart rate variability as a marker and predictor of inflammation, nosocomial infection, and sepsis \u2013 A systematic review.","volume":"249","author":"Adam","year":"2023","journal-title":"Auton Neurosci"},{"key":"R32-20261005","doi-asserted-by":"crossref","first-page":"e149633","DOI":"10.1172\/JCI149633","article-title":"Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.","volume":"131","author":"Yonker","year":"2021","journal-title":"J Clin Invest"},{"key":"R33-20261005","doi-asserted-by":"crossref","first-page":"e151467","DOI":"10.1172\/JCI151467","article-title":"Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children.","volume":"131","author":"Hensley-McBain","year":"2021","journal-title":"J Clin Invest"},{"key":"R34-20261005","doi-asserted-by":"crossref","first-page":"103321","DOI":"10.1016\/j.arcmed.2025.103321","article-title":"Regulation of intestinal permeability in health and disease: Possible therapeutic applications.","volume":"57","author":"Guemes-Gonzalez","year":"2026","journal-title":"Arch Med Res"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000004063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:01:12Z","timestamp":1791208872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000004063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000004063","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]}}}